Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 10, 2025 • 9:31 AM ET

Date/Time Source News Release
06/27/2025 07:00 AM EDT Newsfile InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
06/25/2025 08:00 AM EDT Newsfile InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
06/24/2025 07:00 AM EDT Newsfile InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
06/13/2025 04:30 PM EDT Newsfile InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA
05/12/2025 06:00 PM EDT Newsfile InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
02/12/2025 06:54 PM EST Newsfile InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
02/03/2025 07:30 AM EST Newsfile InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
01/22/2025 07:30 AM EST Newsfile InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
01/21/2025 07:30 AM EST Newsfile InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
12/18/2024 08:00 PM EST Newsfile InMed Announces Results of 2024 Annual General Meeting
Page

Additional News

As of July 10, 2025 • 9:31 AM ET

Date/Time Source News Release
07/09/2025 05:38 PM EDT SeekingAlpha InMed Pharmaceuticals registers 3.9M shares for resale
06/25/2025 08:54 AM EDT SeekingAlpha InMed Pharmaceuticals announces $5M private placement
06/24/2025 02:22 PM EDT BioMedWire BioMedNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer's Neuroinflammation Model
06/24/2025 11:57 AM EDT 24/7 Market News Midday Market Notes: June 24, 2025
06/02/2025 10:29 AM EDT IBN Spotlights InMed Pharmaceuticals Inc. (NASDAQ: INM) Sees Notable Increase in Monday Morning Market Activity
06/02/2025 09:04 AM EDT 24/7 Market News Siyata Mobile's $160M Core Gaming Merger Closing Date Nears Without Advance Notice
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - InMed Pharmaceuticals Inc.
05/12/2025 06:02 PM EDT SeekingAlpha InMed Pharmaceuticals Non-GAAP EPS of -$1.94, revenue of $1.26M
02/13/2025 02:33 AM EST SeekingAlpha InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
Page